IP Library Granted Patent US 10,398,557
Granted Patent B2
US 10,398,557 · App. 15/387,464 · Granted Sep 3, 2019

Method and device for percutaneous left ventricular reconstruction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,398,557
App. No.
15/387,464
Granted
Sep 3, 2019
Kind
B2
Abstract

A method for reducing left ventricular volume, which comprises identifying infracted tissue during open chest surgery; reducing left ventricle volume while preserving the ventricular apex; and realigning the ventricular apex, such that the realigning step comprises closing the lower or apical portion of said ventricle to achieve appropriate functional contractile geometry of said ventricle in a dyskinetic ventricle of a heart.

Claims (15)

1. A system for reducing a chamber volume in a heart comprising:

a suction device that is configured to apply suction to an epicardium of said chamber to bring opposing walls of said chamber into contact with one another and thereby reduce a size of said chamber, said opposing walls including a first wall and a second wall; and

a needle that is configured to penetrate across said first and second walls of said chamber with said first wall contacting said second wall;

wherein said suction device is configured to engage the epicardium and apply suction so that the epicardium is drawn into the suction device and the opposing walls are brought into contact with one another.

2. The system of claim 1 , wherein said suction device is configured to apply suction to the epicardium to draw the epicardium into the suction device so that inner surfaces of said first wall and second wall are brought into contact with one another.

3. The system of claim 1 , further comprising a tissue sensing element that is configured to sense infarcted tissue of the first wall or second wall.

4. The system of claim 3 , wherein the tissue sensing element is configured to sense the infarcted tissue via pacing, angiography, echocardiography, or tissue Doppler.

5. The system of claim 1 , further comprising:

a clamp element that is configured to clamp said first and second walls; and

a securing element for securing a clamped portion of said first and second walls.

6. The system of claim 5 , further comprising a patch that is configured for application over the clamped portion of said first and second walls.

7. The system of claim 6 , wherein the patch comprises a woven Dacron material or an extracellular matrix.

8. The system of claim 1 , further comprising stitches that are applicable to said first and second walls of said chamber to affix said first and second walls together, said stitching penetrating through said first and second walls to affix said walls together to achieve appropriate functional contractile geometry of said chamber.

9. The system of claim 1 , wherein said suction device and needle are configured for delivery to the heart via a minimally invasive procedure.

10. The system of claim 1 , further comprising a thoracoscope or camera that is positionable into an incision to facilitate visualization of the epicardium during reducing of the chamber volume.

Assignments (2)
MERGER Recorded Mar 7, 2017
From: CHF TECHNOLOGIES, INC.
To: BIOVENTRIX, INC.
Reel/Frame 041489/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2017
From: CHIN, SING-FATT; BERTOLERO, ARTHUR; ANNEST, LON
To: CHF TECHNOLOGIES, INC.
Reel/Frame 041478/0799 →
Cited By (1)
US 12,533,235